Home / Piperacillin and Beta-Lactamase Inhibitor / Canada
CA ATC J01CR05 · updated 2 Nov 2026
Piperacillin and Beta-Lactamase Inhibitor shortage in Canada
Is there a Piperacillin and Beta-Lactamase Inhibitor shortage in Canada?
Yes. As of 2 Nov 2026, 7 Piperacillin and Beta-Lactamase Inhibitor products are reported short in Canada, the first since 1 Oct 2014. The company estimate for the return is 6 Nov 2026. Main reason: manufacturing problem.
Also short in United States, Italy, Belgium, Switzerland, Czechia, Sweden, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PIPERACILLIN AND TAZOBACTAM FOR INJECTION (30 ML) | APOTEX INC | 1 Oct 2014 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PIPERACILLIN AND TAZOBACTAM FOR INJECTION (30 ML) | APOTEX INC | 7 Sep 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PIPERACILLIN AND TAZOBACTAM FOR INJECTION (48 ML) | APOTEX INC | 7 Sep 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PIPERACILLIN AND TAZOBACTAM FOR INJECTION (10PSOIJ) | SANDOZ CANADA INCORPORATED | 2 Nov 2026 | 6 Nov 2026 | Distribution or logistics Delay in shipping of the drug |
| CA | PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2.25G) discontinuation | HIKMA CANADA LIMITED | not given | not given | Not stated |
| CA | PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3.375G) discontinuation | HIKMA CANADA LIMITED | not given | not given | Not stated |
| CA | PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4.5G) discontinuation | HIKMA CANADA LIMITED | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.